| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
26,320,000 |
| Market
Cap: |
3.83(M) |
| Last
Volume: |
169,426 |
Avg
Vol: |
168,966 |
| 52
Week Range: |
$0.1454 - $0.1454 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. Co. is developing multiple precision-targeted products based on its Manocept™ platform to improve patient care by identifying the sites and pathways of undetected disease and enable diagnostic, clinical decision-making and targeted treatment. Co.'s business is focused on two primary types of drug products: diagnostic substances, including Tc99m tilmanocept and other diagnostic applications of its Manocept platform; and therapeutic development programs, including therapeutic applications of its Manocept platform.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rowinsky Eric K |
Director |
– • – |
2011-08-19 |
4 |
B |
$2.55 |
$38,250 |
D/D |
15,000 |
15,000 |
2.39 |
- |
|
| Bupp David C |
Director |
– • – |
2011-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
2,900,328 |
|
- |
|
| Bupp David C |
Director |
– • – |
2011-06-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
13,000 |
2,600,328 |
|
- |
|
| Bupp David C |
Director |
– • – |
2011-06-03 |
4 |
AS |
$4.52 |
$1,057,680 |
D/D |
(234,000) |
2,613,328 |
|
- |
|
| Bupp David C |
Director |
– • – |
2011-06-02 |
4 |
AS |
$4.74 |
$1,104,420 |
D/D |
(233,000) |
2,547,328 |
|
- |
|
| Bupp David C |
Director |
– • – |
2011-06-01 |
4 |
AS |
$5.00 |
$1,165,000 |
D/D |
(233,000) |
2,780,328 |
|
- |
|
| Blair Anthony K |
VP-Manufacturing & Operations |
• – – |
2011-05-27 |
4 |
S |
$5.22 |
$261,000 |
D/D |
(50,000) |
0 |
|
- |
|
| Bupp David C |
Director |
– • – |
2011-05-27 |
4 |
OE |
$0.00 |
$0 |
I/I |
20,000 |
213,746 |
|
- |
|
| Bupp David C |
Director |
– • – |
2011-05-27 |
4 |
OE |
$0.31 |
$243,200 |
D/D |
770,000 |
3,013,328 |
|
- |
|
| Aschinger Carl J Jr |
Director |
– • – |
2011-05-27 |
4 |
S |
$5.03 |
$402,400 |
D/D |
(80,000) |
158,300 |
|
- |
|
| Bupp David C |
Director |
– • – |
2011-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
2,543,328 |
|
- |
|
| Bupp David C |
Director |
– • – |
2011-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
400,000 |
2,243,328 |
|
- |
|
| Bupp David C |
CEO and President |
• • – |
2011-04-13 |
4 |
D |
$0.32 |
$203,943 |
D/D |
(637,321) |
1,843,328 |
|
- |
|
| Bupp David C |
CEO and President |
• • – |
2011-04-13 |
4 |
OE |
$0.13 |
$492,700 |
D/D |
1,525,000 |
2,480,649 |
|
- |
|
| Aschinger Carl J Jr |
Director |
– • – |
2010-12-24 |
4 |
B |
$1.95 |
$215 |
I/I |
110 |
320 |
2.02 |
- |
|
| Aschinger Carl J Jr |
Director |
– • – |
2010-12-20 |
4 |
B |
$1.92 |
$192 |
I/I |
100 |
210 |
2.02 |
- |
|
| Aschinger Carl J Jr |
Director |
– • – |
2010-12-20 |
4 |
B |
$1.95 |
$215 |
I/I |
110 |
110 |
2.02 |
- |
|
| Brown Rodger A |
Vice President |
• – – |
2010-12-14 |
4 |
D |
$1.97 |
$41,931 |
D/D |
(21,285) |
28,715 |
|
- |
|
| Brown Rodger A |
Vice President |
• – – |
2010-12-14 |
4 |
OE |
$0.41 |
$18,450 |
D/D |
45,000 |
50,000 |
|
- |
|
| Larson Brent L |
VP Finance and CFO |
• – – |
2010-12-14 |
4 |
D |
$1.97 |
$55,909 |
D/D |
(28,380) |
154,912 |
|
- |
|
| Larson Brent L |
VP Finance and CFO |
• – – |
2010-12-14 |
4 |
OE |
$0.41 |
$24,600 |
D/D |
60,000 |
183,292 |
|
- |
|
| Johnson Owen E |
Director |
– • – |
2010-12-08 |
4 |
B |
$2.05 |
$51,230 |
D/D |
25,000 |
70,000 |
2.39 |
- |
|
| Cope Frederick O |
Vice President |
• – – |
2010-11-17 |
4 |
B |
$1.76 |
$8,800 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
| Troup Gordon A |
Director |
– • – |
2010-11-15 |
4 |
B |
$1.75 |
$17,450 |
D/D |
10,000 |
40,000 |
2.39 |
- |
|
| Ford Brendan A |
Director |
– • – |
2010-11-15 |
4 |
B |
$1.73 |
$52,575 |
D/D |
30,000 |
30,000 |
2.39 |
- |
|
411 Records found
|
|
Page 12 of 17 |
|
|
